SNPS heads into its September 30 earnings date with two bellwether upgrades in hand, short sellers quietly adding to positions, and a stock trading well below where the Street thinks it belongs.
The most newsworthy development this week is the analyst pivot. Morgan Stanley's Lee Simpson upgraded to Overweight on September 8, maintaining a $500 target — a firm that had been sitting on the sidelines at Equal-Weight since August. Two days later, Wells Fargo's Joe Quatrochi followed with its own upgrade to Overweight, lifting the target to $475 from $450. Both moves came within two weeks of each other, both from analysts who had been cautious. The broader Street remains firmly constructive: 17 buys versus just 2 holds, with a consensus price target of $546 against a current price of $397. That implies roughly 37% upside from here. The August earnings print almost certainly drove the recalibration — the stock jumped nearly 14% on the day of its Q3 results, when management beat expectations and raised full-year guidance.
Positioning in the lending market tells a different, calmer story. Borrow availability for SNPS is exceptionally loose — nearly 8,000% of shares already borrowed remain available to lend, a level that signals no meaningful squeeze pressure whatsoever. Borrowing costs run at just 0.43%, barely above the risk-free rate, with the cost actually lower than a week ago despite the rise in short positions. Short interest ticked up 18% over the past week to roughly 2.9% of the free float, reversing a month-long decline. That level is not extreme — it sits at the lower bound of what would typically attract attention — but the direction of travel is worth noting. The ORTEX short score has crept from 31.9 to 33.5 across the past two weeks, a mild but consistent drift upward. Put/call ratio at 1.17 is actually running just below its 20-day average of 1.20, and well within normal range, suggesting options traders are not expressing any fresh anxiety going into the earnings date.
Bulls are leaning on the ANSS acquisition synergies, AI-driven chip design complexity pushing EDA tool adoption, and a recurring revenue model that insulates the business from order-cycle volatility. The company's forward earnings estimates have been revised sharply higher — the 12-month forward EPS growth reading scores in the 67th percentile on ORTEX's factor universe, and 30-day EPS momentum ranks in the 75th percentile. The analyst recommendation divergence factor is even more striking, scoring in the 99th percentile — meaning the Street's conviction in SNPS is among the widest positive spreads in the entire coverage universe. Bears counter with real concerns: customer concentration among a narrowing group of leading-edge foundries and fabless customers, integration execution risk from ANSS, and valuation risk on a name that was trading north of $600 before a sustained de-rating. The PE ratio has contracted roughly 7% in the past 30 days to about 23.7x, and EV/EBITDA has softened too, drifting down about 2.7% over the same period — modest moves, but in the direction of re-rating lower even as earnings revisions move the other way.
Executive Chair Aart de Geus sold just over $21 million in shares across two tranches on August 31 and September 1, both under a pre-arranged 10b5-1 plan. Plan-driven sales carry far less signal than discretionary transactions, and at 90-day net insider sales of roughly $40.7 million, the headline figure looks larger than the underlying picture. No open-market purchases have been registered from senior management in the recent window. The closest peer, CDNS, fell 5% on the week while SNPS gained 0.9% — a modest outperformance that at least suggests the market is treating the two names somewhat differently after the earnings gap.
With September 30's Q4 print now roughly three weeks away, the question crystallising is whether the post-Q3 upgrade wave can be sustained or whether the stock's persistent discount to consensus targets closes before results — or widens further on any guidance miss.
See the live data behind this article on ORTEX.
Open SNPS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
